Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122889 · ClinicalTrials.gov registry record
Effects of Garlic Supplements on Drug Metabolism
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00122889 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 80 participants.
The verdict
NCT00122889 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study will determine whether garlic supplements affect the way certain drugs are processed in the body.
Interventions
- DRUG Garlic powder with high allicin content
- DRUG Garlic powder with low allicin content
- DRUG Garlic oil
- DRUG Aged garlic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-07 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00122889
The ClinicalTrials.gov registry entry for NCT00122889 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Garlic powder with high allicin content is the first listed.
NCT00122889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00122889 about?
NCT00122889 is a clinical study titled "Effects of Garlic Supplements on Drug Metabolism". This study will determine whether garlic supplements affect the way certain drugs are processed in the body.
What is the current status of trial NCT00122889?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2005-07. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00122889?
The interventions under investigation include: Garlic powder with high allicin content (DRUG), Garlic powder with low allicin content (DRUG), Garlic oil (DRUG), Aged garlic (DRUG).
Who is sponsoring clinical trial NCT00122889?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.